Imperial College London

Jiri Pavlu

Faculty of MedicineDepartment of Immunology and Inflammation

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 3313 8117j.pavlu Website

 
 
//

Location

 

Leuka Building R2.20Hammersmith HospitalHammersmith Campus

//

Summary

 

Summary

Jiri Pavlu is a Consultant Haematologist at Hammersmith Hospital and Honorary Clinical Senior Lecturer at Imperial College London. He graduated from the First Faculty of Medicine of Charles University in Prague in 1998. In completing this he was part of the research group of Professor Gordon-Smith at St.Georges Hospital Medical School in London and obtained his research degree in molecular haematology. He completed his specialist haematology training in London on the Royal Free and Hammersmith rotation.

He has developed a specialist interest in haematopoietic stem cell transplantation, particularly for leukaemia. He is the clinical lead for acute leukaemia and myelodysplastic syndromes and a stem cell transplant clinical and collection facility director. Together with Gill Brisley, clinical nurse specialist, and the transplant coordinators he runs relevant specialist haematology clinics at Hammersmith Hospital. He is a principal investigator and subinvestigator of various clinical trials, an active member of the European Group for Blood and Marrow Transplantation (EBMT) Acute leukaemia working party and also an accredited inspector for the Joint Accreditation Committee – International Society for Cellular Therapy (Europe) & EBMT.

Secretary: +44 (0) 2083838117, +44 (0) 2083835030
Fax: +44 (0) 2033133965

Publications

Journals

Craddock C, Jackson A, Loke J, et al., 2021, Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia., J Clin Oncol, Vol:39, Pages:768-778

Ellington MJ, Davies F, Jauneikaite E, et al., 2020, A multi-species cluster of GES-5 carbapenemase producing Enterobacterales linked by a geographically disseminated plasmid, Clinical Infectious Diseases, Vol:71, ISSN:1058-4838, Pages:2553-2560

Conference

Innes AJ, Ghani R, Mullish BH, et al., 2020, O105. Faecal microbiota transplant (FMT) can reduce the high NRM associated with multi-drug resistant organism (MDRO) colonisation prior to allogeneic HCT., The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation, Springer Nature [academic journals on nature.com], Pages:122-122, ISSN:0268-3369

Giebel S, Labopin M, Angelucci E, et al., 2020, Total Body Irradiation/Fludarabine Versus Thiotepa/ busulfan/fludarabine for Adults with Acute Lymphoblastic Leukemia Treated with Haploidentical HCT. A Study by Acute Leukemia Working Party of the EBMT, SPRINGERNATURE, Pages:65-65, ISSN:0268-3369

Devillier R, Galimard J-E, Labopin M, et al., 2020, Reduced Intensity Vs. Non-Myeloablative Conditioning Regimens for Haploidentical Transplantation in Complete Remission Acute Myeloid Leukemia: A Study from the ALWP of the EBMT, AMER SOC HEMATOLOGY, ISSN:0006-4971

More Publications